Stempeutics eyes late-stage trial waiver for stem-cell drug – Livemint
Livemint |
Stempeutics eyes late-stage trial waiver for stem–cell drug
Livemint Stempeucel, made from stem cells from bone marrow, is used to treat a rare condition of reduced blood flow to limbs from Buerger's disease. Roughly 2 million Indians suffer from this disease. “Now that we have completed phase two trials on 120 patients … Stempeutics' stem cell drug, Stempeucel receives European Orphan Drug … Stempeutics Receives Orphan Drug Designation (ODD) in the European Union … Stempeutics' Stempeucel gets Orphan Drug status in Europe |
